I don't think it is PH3 for once a day Oxy. But there are divergent paths that are unclear to me. If Oxy is off patent, then a 505B2 would be in order as a generic. Do they get to use the PH1 and 2 data from the trials to support this product? There is much that is not clear except the end game which is a generic ART opioid.
505B2s do not require a full blown PH3. These can be studies too but not just BE studies but it gets more complicated as you go through it.
(0)
(0)
Elite Pharmaceuticals Inc (ELTP) Stock Research Links